Prothena Corp Public (PRTA) FCF Margin Growth (1y) (2013 - 2026)
Prothena Corp Public (PRTA) FCF Margin Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,187.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,525.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -341.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Prothena Corp Public | 458.13 Mn | 128.67 Mn | - | 194,497.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 194,497.00 |
| Dec 31, 2025 | -10.88 Mn |
| Sep 30, 2025 | 297,915.00 |
| Jun 30, 2025 | -106,234.00 |
| Mar 31, 2025 | 14.44 Mn |
| Dec 31, 2024 | 1.44 Mn |
| Sep 30, 2024 | -466,997.00 |
| Jun 30, 2024 | 114,903.00 |
| Mar 31, 2024 | -14.41 Mn |
| Dec 31, 2023 | -1.66 Mn |
| Sep 30, 2023 | 207,378.00 |
| Jun 30, 2023 | 156,295.00 |
| Mar 31, 2023 | 105,670.00 |
| Dec 31, 2022 | 193,316.00 |
| Sep 30, 2022 | -214,349.00 |
| Jun 30, 2022 | -276,096.00 |
| Mar 31, 2022 | 1.78 Mn |
| Dec 31, 2021 | 337,463.00 |
| Sep 30, 2021 | 1.25 Mn |
| Jun 30, 2021 | 967,275.00 |